The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 22, 2023
Filed:
Oct. 18, 2017
Applicant:
Australian Foundation for Diabetes Research, Maroubra, AU;
Inventors:
Bernard Tuch, Maroubra, AU;
Tim Dargaville, The Gap, AU;
Auvro Mridha, Glenfield, AU;
Paul Dalton, Bavaria, DE;
Vijayaganapathy Vaithilingam, Pondicherry, IN;
Assignee:
AUSTRALIAN FOUNDATION FOR DIABETES RESEARCH, Maroubra, AU;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61L 27/54 (2006.01); A61L 27/56 (2006.01); A61L 27/20 (2006.01); A61K 35/39 (2015.01); A61L 27/38 (2006.01); A61P 3/10 (2006.01); A61K 47/34 (2017.01); A61F 2/02 (2006.01); B33Y 80/00 (2015.01); B33Y 70/00 (2020.01); A61K 38/28 (2006.01); A61L 27/18 (2006.01); A61P 1/16 (2006.01); A61P 25/16 (2006.01); B33Y 10/00 (2015.01); A61F 2/00 (2006.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 9/0024 (2013.01); A61F 2/022 (2013.01); A61K 35/39 (2013.01); A61K 38/28 (2013.01); A61K 47/34 (2013.01); A61L 27/18 (2013.01); A61L 27/20 (2013.01); A61L 27/3804 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); A61P 1/16 (2018.01); A61P 3/10 (2018.01); A61P 25/16 (2018.01); B33Y 80/00 (2014.12); A61F 2002/0086 (2013.01); A61K 2035/128 (2013.01); A61L 2300/252 (2013.01); A61L 2300/43 (2013.01); A61L 2300/62 (2013.01); A61L 2300/64 (2013.01); B33Y 10/00 (2014.12);
Abstract
The present invention relates to the use of scaffolds to enhance the viability of cells implanted in the integumentary system such that the cell may release an agent. The scaffold is capable of protecting the cell, as well as allowing for adequate nutrient delivery at the implant site through vascularisation in and around the scaffold.